Effect of Concomitant Deletions of CDKN2A/B, PAX5 and Pseudoautosomal Region Genes along with IKZF1 Deletions (IKZF1-Plus) on Outcome in BCR-ABL1 Negative Pediatric B-Cell Acute Lymphoblastic Leukemia

被引：0

作者：

Gupta, Sanjeev Kumar ^{[1
]}

Bakhshi, Sameer ^{[2
]}

Gupta, Ritu ^{[1
]}

Kamal, Vineet Kumar ^{[3
]}

Sahoo, Ranjit Kumar ^{[2
]}

Sharma, Atul ^{[2
]}

Kumar, Lalit ^{[2
]}

机构：

[1] AIIMS, Lab Oncol Unit, IRCH, New Delhi, India

[2] AIIMS, Dept Med Oncol, IRCH, New Delhi, India

[3] Natl Inst Epidemiol, Div Epidemiol & Biostat, Chennai, Tamil Nadu, India

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷

关键词：

ALL; acute lymphoblastic leukemia; B-ALL genetics; IKZF1 deletions in ALL; IKZF1-plus; CDKN2A/B deletions; PAX5; deletions;

D O I：

10.1016/j.clml.2019.07.050

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ALL-354

引用

页码：S198 / S199

页数：2

共 50 条

[41] Effect of IKZF1 Deletions on Signal Transduction Pathways in Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
van der Sligte, Naomi E.
Scherpen, Frank J. G.
ter Elst, Arja
Guryev, Victor
van Leeuwen, Frank N.
de Bont, Evelina S. J. M.
BLOOD, 2014, 124 (21)
[42] Incidence and biological significance of IKZF1/lkaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia
Qazi, Sanjive
Uckun, Fatih M.
HAEMATOLOGICA, 2013, 98 (12) : E151 - E152
[43] An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
Clappier, E.
Auclerc, M-F
Rapion, J.
Bakkus, M.
Caye, A.
Khemiri, A.
Giroux, C.
Hernandez, L.
Kabongo, E.
Savola, S.
Leblanc, T.
Yakouben, K.
Plat, G.
Costa, V.
Ferster, A.
Girard, S.
Fenneteau, O.
Cayuela, J-M
Sigaux, F.
Dastugue, N.
Suciu, S.
Benoit, Y.
Bertrand, Y.
Soulier, J.
Cave, H.
LEUKEMIA, 2014, 28 (01) : 70 - 77
[44] An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
E Clappier
M-F Auclerc
J Rapion
M Bakkus
A Caye
A Khemiri
C Giroux
L Hernandez
E Kabongo
S Savola
T Leblanc
K Yakouben
G Plat
V Costa
A Ferster
S Girard
O Fenneteau
J-M Cayuela
F Sigaux
N Dastugue
S Suciu
Y Benoit
Y Bertrand
J Soulier
H Cavé
Leukemia, 2014, 28 : 70 - 77
[45] Better Prognosis of Dominant-Negative Type of IKZF1 Deletion in BCR-ABL-positive Adult B-Cell Acute Lymphoblastic Leukemia
Kimura, Hiroyuki
Onozawa, Masahiro
Yoshida, Shota
Miyashita, Naoki
Takahashi, Shogo
Yokoyama, Shota
Matsukawa, Toshihiro
Hirabayashi, Shinsuke
Fujisawa, Shinichi
Ota, Shuichi
Hidaka, Daisuke
Mori, Akio
Kondo, Takeshi
Kakinoki, Yasutaka
Tsutsumi, Yutaka
Yamamoto, Satoshi
Miyagishima, Takuto
Nagashima, Takahiro
Ibata, Makoto
Kobayashi, Hajime
Haseyama, Yoshihito
Fujimoto, Katsuya
Ishihara, Toshimichi
Sakai, Hajime
Teshima, Takanori
BLOOD, 2022, 140 : 9207 - 9208
[46] IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients
Iacobucci, Ilaria
Messina, Monica
Iraci, Nunzio
Lonetti, Annalisa
Chiaretti, Sabina
Ferrari, Anna
Papayannidis, Cristina
Messa, Francesca
Vitale, Antonella
Paoloni, Francesca
Cilloni, Daniela
Storlazzi, Clelia Tiziana
Ottaviani, Emanuela
Paolini, Stefania
Durante, Sandra
Soverini, Simona
Guarini, Rita
Vignetti, Marco
Pane, Fabrizio
Saglio, Giuseppe
Foa, Robin
Muschen, Markus
Pfifer, Heike
Ottmann, Oliver
Perini, Giovanni
Baccarani, Michele
Martinelli, Giovanni
BLOOD, 2009, 114 (22) : 376 - 376
[47] The role of IKZF1 deletions in adult Ph-negative and Ph-positive B-cell acute lymphoblastic leukemia patients treated in Russian Acute Lymphoblastic Leukemia study
Baskhaeva, G. A.
Parovichnikova, E. N.
Biderman, B. V.
Gavrilina, O. A.
Davidova, Yu. O.
Drokov, M. Yu.
Zarubina, K. I.
Lukyanova, I. A.
Troitskaya, V. V.
Sokolov, A. N.
Piskunova, I. S.
Stepanova, E. A.
Smirnova, S. A.
Sudarikov, A. B.
Galtseva, I. V.
Obukhova, T. N.
Savchenko, V. G.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2018, 63 (01): : 16 - 30
[48] Leukemia Cells with a BCR-ABL1-Like signature and/or IKZF1 deletions, but Not High CRLF2 Expression, Are Predictive of an Unfavorable Prognosis in Childhood B Cell Precursor Acute Lymphoblastic Leukemia
Van Der Veer, Arian
Waanders, Esmee
Pieters, Rob
Willemse, Marieke E.
Reijmersdaal, Simon
Russell, Lisa J.
Harrison, Christine J.
Evans, William E.
van der Velden, Vincent H. J.
Hoogerbrugge, Peter M.
van Leeuwen, Frank N.
Escherich, G.
Horstman, Martin
Khankandani, Leila Mohamadi
Rizopoulos, Dimitris
de Groot-Kruseman, Hester A.
Sonneveld, Edwin
Kuiper, Roland P.
Den Boer, Monique L.
BLOOD, 2012, 120 (21)
[49] Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia
Wagener, Rabea
Elitzur, Sarah
Brozou, Triantafyllia
Borkhardt, Arndt
EUROPEAN JOURNAL OF MEDICAL GENETICS, 2023, 66 (04)
[50] IKZF1 deletions associate with CRLF2 overexpression leading to a poor in B-cell acute leukaemia
Wolch, Karolyne
Emerenciano, Mariana
Maciel, Ana Luiza Tardem
Barbosa, Thayana da Conceicao
Blunck, Caroline Barbieri
Machado, Amanda de Albuquerque Lopes
da Costa, Elaine Sobral
Bergier, Lavinia Lustosa
Schramm, Marcia Trindade
Ikoma Coltutato, Maura Rosane Valerio
Lins, Marcia Trindade
Aquiar, Thais Ferraz
Mansur, Marcela Barga
TRANSLATIONAL ONCOLOGY, 2022, 15 (01):

← 1 2 3 4 5 →